nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
ADGRL1 is a glucose receptor involved in mediating energy and glucose homeostasis
|
Chhabra, Kavaljit H. |
|
|
67 |
1 |
p. 170-189 |
artikel |
2 |
Adjudin improves beta cell maturation, hepatic glucose uptake and glucose homeostasis
|
Ren, Lipeng |
|
|
67 |
1 |
p. 137-155 |
artikel |
3 |
A first-in-human, open-label Phase 1b and a randomised, double-blind Phase 2a clinical trial in recent-onset type 1 diabetes with AG019 as monotherapy and in combination with teplizumab
|
Mathieu, Chantal |
|
|
67 |
1 |
p. 27-41 |
artikel |
4 |
Apolipoprotein L genes are novel mediators of inflammation in beta cells
|
Paz-Barba, Miriam |
|
|
67 |
1 |
p. 124-136 |
artikel |
5 |
Associations between type 1 diabetes and educational outcomes: an Aotearoa/New Zealand nationwide birth cohort study using the Integrated Data Infrastructure
|
Bowden, Nicholas |
|
|
67 |
1 |
p. 62-73 |
artikel |
6 |
Chronic kidney disease in type 1 diabetes: translation of novel type 2 diabetes therapeutics to individuals with type 1 diabetes
|
Sridhar, Vikas S. |
|
|
67 |
1 |
p. 3-18 |
artikel |
7 |
Correction to: Cell-autonomous programming of rat adipose tissue insulin signalling proteins by maternal nutrition
|
Martin-Gronert, Malgorzata S. |
|
|
67 |
1 |
p. 216-217 |
artikel |
8 |
Correction to: Insulin-degrading enzyme ablation in mouse pancreatic alpha cells triggers cell proliferation, hyperplasia and glucagon secretion dysregulation
|
Merino, Beatriz |
|
|
67 |
1 |
p. 218-219 |
artikel |
9 |
Correction to: Pancreatic T cell protein–tyrosine phosphatase deficiency affects beta cell function in mice
|
Xi, Yannan |
|
|
67 |
1 |
p. 215 |
artikel |
10 |
Dyslipidaemia as a target for atherosclerotic cardiovascular disease prevention in children with type 1 diabetes: lessons learned from familial hypercholesterolaemia
|
Corpeleijn, Willemijn E. |
|
|
67 |
1 |
p. 19-26 |
artikel |
11 |
Female sex is a risk factor for painful diabetic peripheral neuropathy: the EURODIAB prospective diabetes complications study
|
Elliott, Jackie |
|
|
67 |
1 |
p. 190-198 |
artikel |
12 |
Glycaemia risk index uncovers distinct glycaemic variability patterns associated with remission status in type 1 diabetes
|
Zhong, Ting |
|
|
67 |
1 |
p. 42-51 |
artikel |
13 |
Multi-omic prediction of incident type 2 diabetes
|
Carrasco-Zanini, Julia |
|
|
67 |
1 |
p. 102-112 |
artikel |
14 |
Non-invasive imaging of sympathetic innervation of the pancreas in individuals with type 2 diabetes
|
Vyakaranam, Achyut Ram |
|
|
67 |
1 |
p. 199-208 |
artikel |
15 |
Novel time-resolved reporter mouse reveals spatial and transcriptional heterogeneity during alpha cell differentiation
|
Himuro, Miwa |
|
|
67 |
1 |
p. 156-169 |
artikel |
16 |
Oral magnesium supplementation does not affect insulin sensitivity in people with insulin-treated type 2 diabetes and a low serum magnesium: a randomised controlled trial
|
Drenthen, Linda C. A. |
|
|
67 |
1 |
p. 52-61 |
artikel |
17 |
Paediatric diabetes subtypes in a consanguineous population: a single-centre cohort study from Kurdistan, Iraq
|
Amaratunga, Shenali A. |
|
|
67 |
1 |
p. 113-123 |
artikel |
18 |
Sex influences health: reporting on female characteristics should be mandatory in exercise and physical activity-related diabetes research
|
Yardley, Jane E. |
|
|
67 |
1 |
p. 209-210 |
artikel |
19 |
The metabolic potential of inflammatory and insulinaemic dietary patterns and risk of type 2 diabetes
|
Lee, Dong Hoon |
|
|
67 |
1 |
p. 88-101 |
artikel |
20 |
The metabolomic signature of weight loss and remission in the Diabetes Remission Clinical Trial (DiRECT)
|
Corbin, Laura J. |
|
|
67 |
1 |
p. 74-87 |
artikel |
21 |
Up Front
|
|
|
|
67 |
1 |
p. 1-2 |
artikel |
22 |
Using race as a social construct when looking at differences in racial associations between non-alcoholic fatty liver disease and type 2 diabetes
|
Rollin, Francois G. |
|
|
67 |
1 |
p. 211-212 |
artikel |
23 |
Using race as a social construct when looking at differences in racial associations between non‑alcoholic fatty liver disease and type 2 diabetes. Reply to Rollin FG, Washington C, Fluker S-A [letter]
|
Hatano, Yu |
|
|
67 |
1 |
p. 213-214 |
artikel |